Topical non-steroidal anti-inflammatory drug inhibitors (NSAIDs), such as diclofenac, can inhibit COX-2 locally and may have a role in preventing HFS, without systemic side effects. This evidence concerns the gene PTGS2 and Hand-foot syndrome.